164 results match your criteria: "Olivia Newton John Cancer Wellness and Research Centre[Affiliation]"

Introduction: Locoregional recurrence (LR) is common in locally advanced head and neck cancer (HNSCC), posing challenges for treatment. We analysed outcome parameters and toxicities for patients being treated with radiotherapy (RT) for LR-HNSCC and investigated patient and disease related prognostic factors in this prognostically unfavourable group.

Methods: This analysis includes 101 LR-HNSCC patients treated with RT, radio-chemotherapy (RCT) or radio-immunotherapy (RIT) between 2010 and 2018 at a high-volume tertiary centre.

View Article and Find Full Text PDF

Introduction: Resection of primary tumor and liver metastases is the gold standard for colorectal cancer with liver-only metastases (CRLM). Although treatment options have expanded to enable conversion of unresectable to resectable CRLM, about 40% of patients will have definitively unresectable disease. Major advances in surgical techniques, immunosuppressive protocols and patient selection criteria for liver transplantation have resulted in improved outcomes.

View Article and Find Full Text PDF

StrataXRT and Mepitel Film for Preventing Postmastectomy Acute Radiation Dermatitis in Breast Cancer: An Intrapatient Noninferiority Randomized Clinical Trial.

Int J Radiat Oncol Biol Phys

November 2024

Genesis Care Victoria, Ringwood Private Hospital, Ringwood East, Victoria, Australia; Olivia Newton John Cancer Wellness and Research Centre, Austin Hospital, Heidelberg, Victoria, Australia; Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health CareFaculty of Medicine, Nursing and Health Sciences Monash University, Clayton, Victoria, Australia; University of Melbourne, Melbourne, Victoria, Australia.

Purpose: Acute radiation dermatitis (ARD) is a notable challenge for patients with breast cancer undergoing postmastectomy radiation therapy (RT). This study evaluates the efficacy, safety, and user experience of StrataXRT versus Mepitel Film for ARD prevention.

Methods And Materials: This multicenter, noninferiority trial involved intrapatient randomization of 44 patients with histologically confirmed breast carcinoma who had undergone postmastectomy RT across 4 Australian hospitals from January 1 to December 31, 2017.

View Article and Find Full Text PDF

Becoming the radiation therapist: Exploring the transition to practice experiences of Australian radiation therapist graduates.

Radiography (Lond)

November 2024

Department of Medical Imaging and Radiation Sciences, Monash University, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Australia.

Introduction: The transition to qualified practice for health practitioner graduates can be a challenging experience. Supportive transition to practice programs for graduates are typical in nursing, however they are less common in allied health. Investigations into the transition to practice experience of radiation therapist (RT) graduates specifically have been limited.

View Article and Find Full Text PDF

Objective: Cancer presents a significant health challenge, particularly within culturally and linguistically diverse (CALD) populations. Religious, spiritual, and personal beliefs regarding illness may mitigate its psychological and physical impacts, varying with CALD status. This study aims to assess illness perceptions in Australian cancer patients from both CALD and Anglo-Australian backgrounds and to explore the associations between spiritual wellbeing and illness perceptions within these groups.

View Article and Find Full Text PDF
Article Synopsis
  • * Research is examining ways to lessen treatment intensity (de-escalation), particularly to reduce side effects from radiotherapy while maintaining effective cancer management for HPV-positive patients.
  • * Although some Phase II trials show promise for de-escalation strategies, current Phase III trials have not yet shown improved outcomes, indicating a need for more research and better risk assessment before these strategies can be routinely used outside clinical trials.
View Article and Find Full Text PDF

Pleural-based primary thoracic Epstein-Barr virus-associated lymphoepithelial carcinoma.

Pathology

September 2024

Department of Medical Oncology, Austin Hospital, Heidelberg, Vic, Australia; Olivia Newton-John Cancer Wellness and Research Centre, Heidelberg, Vic, Australia; La Trobe University School of Cancer Medicine, Bundoora, Vic, Australia. Electronic address:

View Article and Find Full Text PDF

Research productivity of RANZCR radiation oncology trainees from 2014 to 2023.

J Med Imaging Radiat Oncol

October 2024

Alfred Health Radiation Oncology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.

Introduction: The aim of this study was to describe the research productivity among RANZCR Radiation Oncology (RO) trainees.

Methods: Publicly available data on RO fellows, who were awarded the RANZCR fellowship between July 2014 and June 2023, was extracted from the RANZCR Annual Reports. Fellows who had qualified overseas and did not undertake full RANZCR training were excluded.

View Article and Find Full Text PDF

Study protocol: Optimising patient positioning for the planning of accelerated partial breast radiotherapy for the integrated magnetic resonance linear accelerator: OPRAH MRL.

Radiat Oncol

September 2024

Department of Medical Imaging and Radiation Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Wellington Rd, Clayton, VIC, 3800, Australia.

Background: Accelerated partial breast irradiation (APBI) is an accepted treatment option for early breast cancer. Treatment delivered on the Magnetic Resonance integrated Linear Accelerator (MRL) provides the added assurance of improved soft tissue visibility, important in the delivery of APBI. This technique can be delivered in both the supine and prone positions, however current literature suggests that prone treatment on the MRL is infeasible due to physical limitations with bore size.

View Article and Find Full Text PDF

Potential of MRI in Assessing Treatment Response After Neoadjuvant Radiation Therapy Treatment in Breast Cancer Patients: A Scoping Review.

Clin Breast Cancer

January 2025

Department of Medical Imaging and Radiation Sciences, School of Primary and Allied Health Care, Monash University, Melbourne, Australia.

The objective of this scoping review is to evaluate the potential of Magnetic Resonance Imaging (MRI) and to determine which of the available MRI techniques reported in the literature are the most promising for assessing treatment response in breast cancer patients following neoadjuvant radiotherapy (NRT). Ovid Medline, Embase, CINAHL, and Cochrane databases were searched to identify relevant studies published from inception until March 13, 2023. After primary selection, 2 reviewers evaluated each study using a standardized data extraction template, guided by set inclusion and exclusion criteria.

View Article and Find Full Text PDF

BRAF-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities.

Clin Colorectal Cancer

September 2024

Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.

BRAF-mutant metastatic colorectal cancer represents a distinct molecular phenotype known for its aggressive biological behavior, resistance to standard therapies, and poor survival rates. Improved understanding of the biology of the BRAF oncogene has led to the development of targeted therapies that have paved the way for a paradigm shift in managing this disease. However, despite significant recent advancements, responses to targeted therapies are short-lived, and several challenges remain.

View Article and Find Full Text PDF

Factors that influence presentation to an emergency department during systemic anti-cancer therapy: An exploratory qualitative study.

Eur J Oncol Nurs

June 2024

Department of Nursing, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia; Department of Health Services Research, Peter MacCallum Cancer Centre, Victoria, Australia; Victorian Comprehensive Cancer Centre Alliance, Victoria, Australia.

Purpose: To explore factors that influence presentation to an emergency department during ambulatory systemic anti-cancer therapy.

Methods: This study was an exploratory qualitative study using semi-structured interviews. A purposive sample of adult patients with any cancer who had commenced systemic anti-cancer therapy in the ambulatory setting up to six months prior participated in semi-structured interviews between November 2016-December 2017.

View Article and Find Full Text PDF

[SBRT for primary kidney cancer: Data from the multicentre prospective FASTRACK II study].

Strahlenther Onkol

August 2024

Klinik und Poliklinik für Radioonkologie, Cyberknife- und Strahlentherapie, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Medizinische Fakulät, Universitätsklinikum Köln, Kerpener Straße 62, 50937, Köln, Deutschland.

View Article and Find Full Text PDF

Background: This scoping review aimed to identify and present the evidence describing key motivations for breast cancer screening among women aged ≥ 75 years. Few of the internationally available guidelines recommend continued biennial screening for this age group. Some suggest ongoing screening is unnecessary or should be determined on individual health status and life expectancy.

View Article and Find Full Text PDF

Narrative review of the utility of magnetic resonance imaging in radiotherapy for cervical cancer.

Chin Clin Oncol

April 2024

Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Australia; School of Imaging and Radiation Sciences, Monash University, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.

Background And Objective: In radiotherapy (RT) for locally advanced cervical cancer, high soft tissue contrast on magnetic resonance imaging (MRI) can ensure accurate delineation of target volumes (TVs) and optimal dose distribution to the RT target and organs at risk (OAR). MRI-guided adaptive RT (MRIgART) is a novel technology that revises RT plans according to anatomical changes occurring throughout the treatment to improve target coverage and minimise OAR toxicity. This review aims to assess the evidence and gaps of MRI use in RT planning and MRIgART in the treatment of cervical cancer, as well as challenges in its clinical implementation.

View Article and Find Full Text PDF

[Radiotherapy plus durvalumab for the treatment of locally advanced non-small cell lung cancer-The DOLPHIN trial].

Strahlenther Onkol

July 2024

Klinik und Poliklinik für Radioonkologie, Cyberknife- und Strahlentherapie, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Medizinische Fakultät und Universitätsklinikum Köln, Köln, Deutschland.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the effectiveness and safety of low-dose-rate (LDR) brachytherapy using iodine-125 for young men under 60 with localized low- to intermediate-risk prostate cancer, amid existing concerns among urologists about long-term control and side effects.
  • - A total of 161 patients were analyzed over a median follow-up period of 6.8 years, revealing an impressive biochemical progression-free survival rate of 94% at 8 years and an overall survival rate of 96.9%.
  • - The treatment resulted in minimal severe toxicities, with only 1.9% of patients developing secondary cancers, indicating that LDR brachytherapy could be a highly effective and safe option for younger men diagnosed
View Article and Find Full Text PDF

Purpose: There has been little dedicated research on cancer-related cognitive impairment in patients with aggressive lymphoma. We describe and compare patients' cognitive function with that of healthy controls and patients' wellbeing and distress with general population values. We also explore associations between patients' neuropsychological test performance and self-reported cognitive function and distress.

View Article and Find Full Text PDF

Classification of tumors of the head and neck has evolved in recent decades including a widespread application of molecular testing in tumors of the sinonasal tract, salivary glands, and soft tissues with a predilection for the head and neck. The availability of new molecular techniques has allowed for the definition of multiple novel tumor types unique to head and neck sites. Moreover, an expanding spectrum of immunohistochemical markers specific to genetic alterations facilitates rapid identification of diagnostic molecular abnormalities.

View Article and Find Full Text PDF

Background: Stereotactic ablative body radiotherapy (SABR) is a novel non-invasive alternative for patients with primary renal cell cancer who do not undergo surgical resection. The FASTRACK II clinical trial investigated the efficacy of SABR for primary renal cell cancer in a phase 2 trial.

Methods: This international, non-randomised, phase 2 study was conducted in seven centres in Australia and one centre in the Netherlands.

View Article and Find Full Text PDF

Background And Purpose: Glioblastoma is one of the most common and aggressive primary brain tumours in adults. Though radiation therapy (RT) techniques have progressed significantly in recent decades, patient survival has seen little improvement. However, an area of promise is the use of fluorine-18-fluoroethyltyrosine positron-emission-tomography (F-FET PET) imaging to assist in RT target delineation.

View Article and Find Full Text PDF
Article Synopsis
  • In Australia, breast screening is free every two years for women aged 50-74, but women aged ≥75 can receive screenings without formal invitations.
  • A study with 60 women aged ≥75 explored their experiences, motivations, and understanding of breast cancer screening, revealing limited information about ongoing screenings past age 75.
  • Key findings highlighted a desire to continue screening among regular participants, but lack of communication from healthcare providers left many feeling confused and marginalized regarding their screening options.
View Article and Find Full Text PDF

Validation of the Consumer Health Activation Index (CHAI) in general population samples of older Australians.

PEC Innov

December 2023

Cancer Research, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Objective: To validate the 10-item Consumer Health Activation Index (CHAI), developed in the United States, as an activation measure for interventions targeted at the Australian older general population.

Methods: The study was a cross sectional design. Exploratory factor analysis (EFA) was conducted on survey data from a community sample of participants ( = 250), aged 55-75 years.

View Article and Find Full Text PDF

Antibody drug conjugates for glioblastoma: current progress towards clinical use.

Expert Opin Biol Ther

December 2023

Tumour Targeting Program, Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, Heidelberg, Melbourne, Australia.

Article Synopsis
  • Antibody drug conjugates (ADCs) are effective cancer treatments that combine targeted delivery with potent drugs, and this review focuses on their application in brain tumors.
  • The review highlights different ADC classes tested in primary brain tumors, discusses major clinical trials, and outlines both their successes and limitations in the context of drug development.
  • ADC development for brain tumors has evolved through two main phases, with insights from past trials guiding future strategies that consider the unique biology of these tumors.
View Article and Find Full Text PDF